People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Biotechnology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SARcode Corp | — | Biotechnology | Series C | $99.6M | $1.8B | 2011 |
| NotalVision, Inc. | — | Other Health Care | Series B | $16.4M | $272.2M | 2021 |
| Okogen, Inc. | — | Other | Series A | $8.9M | $9.9M | 2023 |
Quinton Oswald at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Quinton Oswald on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Hall | 1 | 11 |
| Chris Smith | 1 | 7 |
| Robert Alexander | 1 | 6 |
| DENNIS HENNER | 1 | 5 |
| Eric Daniels | 1 | 4 |
| Dan Janney | 1 | 4 |
| Emmett Cunningham | 1 | 4 |
| Thomas Gadek | 1 | 3 |
| Guy Katsav | 1 | 3 |
| Brian Strem | 1 | 2 |
| Garheng A. Kong | 1 | 2 |
| Zvika Slovin | 1 | 2 |
| Eliot Lazar, MD | 1 | 1 |
| Todd A Creech | 1 | 1 |
| Charles Semba | 1 | 1 |
| Mary A Newman | 1 | 1 |
| Martin A Vogelbaum | 1 | 1 |
| Valerie A Smith | 1 | 1 |
| John Burnier | 1 | 1 |
| Joshua Moriarty | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.